nodes	percent_of_prediction	percent_of_DWPC	metapath
Medroxyprogesterone Acetate—AKR1C3—Doxorubicin—pancreatic cancer	0.215	0.36	CbGbCtD
Medroxyprogesterone Acetate—ESR1—Tamoxifen—pancreatic cancer	0.16	0.268	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Tamoxifen—pancreatic cancer	0.0406	0.0678	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Erlotinib—pancreatic cancer	0.0345	0.0577	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Fluorouracil—pancreatic cancer	0.0299	0.05	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Tamoxifen—pancreatic cancer	0.0283	0.0473	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Fluorouracil—pancreatic cancer	0.0209	0.0349	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Tamoxifen—pancreatic cancer	0.0165	0.0275	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Erlotinib—pancreatic cancer	0.014	0.0234	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Irinotecan—pancreatic cancer	0.0126	0.0211	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Docetaxel—pancreatic cancer	0.00926	0.0155	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Sunitinib—pancreatic cancer	0.00922	0.0154	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Doxorubicin—pancreatic cancer	0.0069	0.0115	CbGbCtD
Medroxyprogesterone Acetate—Nausea—Sunitinib—pancreatic cancer	0.000103	0.000343	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Irinotecan—pancreatic cancer	0.000103	0.000342	CcSEcCtD
Medroxyprogesterone Acetate—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000103	0.000341	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000102	0.000341	CcSEcCtD
Medroxyprogesterone Acetate—Jaundice—Epirubicin—pancreatic cancer	0.000102	0.000339	CcSEcCtD
Medroxyprogesterone Acetate—Stomatitis—Epirubicin—pancreatic cancer	0.000102	0.000339	CcSEcCtD
Medroxyprogesterone Acetate—Urinary tract infection—Epirubicin—pancreatic cancer	0.000102	0.000338	CcSEcCtD
Medroxyprogesterone Acetate—Dysuria—Doxorubicin—pancreatic cancer	0.000102	0.000338	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000101	0.000336	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Docetaxel—pancreatic cancer	0.000101	0.000336	CcSEcCtD
Medroxyprogesterone Acetate—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000101	0.000336	CcSEcCtD
Medroxyprogesterone Acetate—Sweating—Epirubicin—pancreatic cancer	0.0001	0.000334	CcSEcCtD
Medroxyprogesterone Acetate—Pollakiuria—Doxorubicin—pancreatic cancer	0.0001	0.000334	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Gemcitabine—pancreatic cancer	0.0001	0.000333	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Docetaxel—pancreatic cancer	9.97e-05	0.000332	CcSEcCtD
Medroxyprogesterone Acetate—Hepatobiliary disease—Epirubicin—pancreatic cancer	9.89e-05	0.000329	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Docetaxel—pancreatic cancer	9.89e-05	0.000329	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Docetaxel—pancreatic cancer	9.89e-05	0.000329	CcSEcCtD
Medroxyprogesterone Acetate—Weight increased—Doxorubicin—pancreatic cancer	9.88e-05	0.000329	CcSEcCtD
Medroxyprogesterone Acetate—Epistaxis—Epirubicin—pancreatic cancer	9.87e-05	0.000328	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Gemcitabine—pancreatic cancer	9.86e-05	0.000328	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Docetaxel—pancreatic cancer	9.83e-05	0.000327	CcSEcCtD
Medroxyprogesterone Acetate—Weight decreased—Doxorubicin—pancreatic cancer	9.82e-05	0.000327	CcSEcCtD
Medroxyprogesterone Acetate—Sinusitis—Epirubicin—pancreatic cancer	9.82e-05	0.000327	CcSEcCtD
Medroxyprogesterone Acetate—Hyperglycaemia—Doxorubicin—pancreatic cancer	9.79e-05	0.000326	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Irinotecan—pancreatic cancer	9.79e-05	0.000326	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Docetaxel—pancreatic cancer	9.73e-05	0.000324	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Docetaxel—pancreatic cancer	9.7e-05	0.000323	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Fluorouracil—pancreatic cancer	9.7e-05	0.000323	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Docetaxel—pancreatic cancer	9.69e-05	0.000322	CcSEcCtD
Medroxyprogesterone Acetate—Infestation—Doxorubicin—pancreatic cancer	9.68e-05	0.000322	CcSEcCtD
Medroxyprogesterone Acetate—Infestation NOS—Doxorubicin—pancreatic cancer	9.68e-05	0.000322	CcSEcCtD
Medroxyprogesterone Acetate—Drowsiness—Doxorubicin—pancreatic cancer	9.68e-05	0.000322	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Docetaxel—pancreatic cancer	9.65e-05	0.000321	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Docetaxel—pancreatic cancer	9.61e-05	0.00032	CcSEcCtD
Medroxyprogesterone Acetate—Bradycardia—Epirubicin—pancreatic cancer	9.56e-05	0.000318	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Gemcitabine—pancreatic cancer	9.54e-05	0.000317	CcSEcCtD
Medroxyprogesterone Acetate—Neuropathy peripheral—Doxorubicin—pancreatic cancer	9.49e-05	0.000316	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Irinotecan—pancreatic cancer	9.46e-05	0.000315	CcSEcCtD
Medroxyprogesterone Acetate—Haemoglobin—Epirubicin—pancreatic cancer	9.44e-05	0.000314	CcSEcCtD
Medroxyprogesterone Acetate—Stomatitis—Doxorubicin—pancreatic cancer	9.44e-05	0.000314	CcSEcCtD
Medroxyprogesterone Acetate—Jaundice—Doxorubicin—pancreatic cancer	9.44e-05	0.000314	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Docetaxel—pancreatic cancer	9.43e-05	0.000314	CcSEcCtD
Medroxyprogesterone Acetate—Urinary tract infection—Doxorubicin—pancreatic cancer	9.41e-05	0.000313	CcSEcCtD
Medroxyprogesterone Acetate—Haemorrhage—Epirubicin—pancreatic cancer	9.39e-05	0.000313	CcSEcCtD
Medroxyprogesterone Acetate—Hepatitis—Epirubicin—pancreatic cancer	9.39e-05	0.000313	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Fluorouracil—pancreatic cancer	9.38e-05	0.000312	CcSEcCtD
Medroxyprogesterone Acetate—Pharyngitis—Epirubicin—pancreatic cancer	9.32e-05	0.00031	CcSEcCtD
Medroxyprogesterone Acetate—Sweating—Doxorubicin—pancreatic cancer	9.28e-05	0.000309	CcSEcCtD
Medroxyprogesterone Acetate—Urinary tract disorder—Epirubicin—pancreatic cancer	9.27e-05	0.000309	CcSEcCtD
Medroxyprogesterone Acetate—Oedema peripheral—Epirubicin—pancreatic cancer	9.25e-05	0.000308	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Docetaxel—pancreatic cancer	9.24e-05	0.000308	CcSEcCtD
Medroxyprogesterone Acetate—Connective tissue disorder—Epirubicin—pancreatic cancer	9.23e-05	0.000307	CcSEcCtD
Medroxyprogesterone Acetate—Urethral disorder—Epirubicin—pancreatic cancer	9.21e-05	0.000306	CcSEcCtD
Medroxyprogesterone Acetate—Hepatobiliary disease—Doxorubicin—pancreatic cancer	9.15e-05	0.000305	CcSEcCtD
Medroxyprogesterone Acetate—Epistaxis—Doxorubicin—pancreatic cancer	9.13e-05	0.000304	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Irinotecan—pancreatic cancer	9.1e-05	0.000303	CcSEcCtD
Medroxyprogesterone Acetate—Sinusitis—Doxorubicin—pancreatic cancer	9.08e-05	0.000302	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Fluorouracil—pancreatic cancer	9.06e-05	0.000302	CcSEcCtD
Medroxyprogesterone Acetate—Visual impairment—Epirubicin—pancreatic cancer	9.05e-05	0.000301	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Irinotecan—pancreatic cancer	9.02e-05	0.0003	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Irinotecan—pancreatic cancer	9.01e-05	0.0003	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	9.01e-05	0.0003	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Irinotecan—pancreatic cancer	8.96e-05	0.000298	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Docetaxel—pancreatic cancer	8.95e-05	0.000298	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Docetaxel—pancreatic cancer	8.88e-05	0.000296	CcSEcCtD
Medroxyprogesterone Acetate—Erythema multiforme—Epirubicin—pancreatic cancer	8.88e-05	0.000295	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Gemcitabine—pancreatic cancer	8.86e-05	0.000295	CcSEcCtD
Medroxyprogesterone Acetate—Bradycardia—Doxorubicin—pancreatic cancer	8.85e-05	0.000294	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Docetaxel—pancreatic cancer	8.82e-05	0.000293	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Docetaxel—pancreatic cancer	8.79e-05	0.000293	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Gemcitabine—pancreatic cancer	8.79e-05	0.000292	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Gemcitabine—pancreatic cancer	8.78e-05	0.000292	CcSEcCtD
Medroxyprogesterone Acetate—Eye disorder—Epirubicin—pancreatic cancer	8.78e-05	0.000292	CcSEcCtD
Medroxyprogesterone Acetate—Tinnitus—Epirubicin—pancreatic cancer	8.76e-05	0.000291	CcSEcCtD
Medroxyprogesterone Acetate—Haemoglobin—Doxorubicin—pancreatic cancer	8.73e-05	0.000291	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Gemcitabine—pancreatic cancer	8.73e-05	0.000291	CcSEcCtD
Medroxyprogesterone Acetate—Cardiac disorder—Epirubicin—pancreatic cancer	8.72e-05	0.00029	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Fluorouracil—pancreatic cancer	8.71e-05	0.00029	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Docetaxel—pancreatic cancer	8.71e-05	0.00029	CcSEcCtD
Medroxyprogesterone Acetate—Hepatitis—Doxorubicin—pancreatic cancer	8.69e-05	0.000289	CcSEcCtD
Medroxyprogesterone Acetate—Haemorrhage—Doxorubicin—pancreatic cancer	8.69e-05	0.000289	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Fluorouracil—pancreatic cancer	8.64e-05	0.000288	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Fluorouracil—pancreatic cancer	8.63e-05	0.000287	CcSEcCtD
Medroxyprogesterone Acetate—Pharyngitis—Doxorubicin—pancreatic cancer	8.62e-05	0.000287	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Docetaxel—pancreatic cancer	8.6e-05	0.000286	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Fluorouracil—pancreatic cancer	8.59e-05	0.000286	CcSEcCtD
Medroxyprogesterone Acetate—Urinary tract disorder—Doxorubicin—pancreatic cancer	8.58e-05	0.000286	CcSEcCtD
Medroxyprogesterone Acetate—Oedema peripheral—Doxorubicin—pancreatic cancer	8.56e-05	0.000285	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Docetaxel—pancreatic cancer	8.54e-05	0.000284	CcSEcCtD
Medroxyprogesterone Acetate—Connective tissue disorder—Doxorubicin—pancreatic cancer	8.54e-05	0.000284	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Docetaxel—pancreatic cancer	8.53e-05	0.000284	CcSEcCtD
Medroxyprogesterone Acetate—Angiopathy—Epirubicin—pancreatic cancer	8.52e-05	0.000284	CcSEcCtD
Medroxyprogesterone Acetate—Urethral disorder—Doxorubicin—pancreatic cancer	8.52e-05	0.000283	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Irinotecan—pancreatic cancer	8.5e-05	0.000283	CcSEcCtD
Medroxyprogesterone Acetate—Immune system disorder—Epirubicin—pancreatic cancer	8.48e-05	0.000282	CcSEcCtD
Medroxyprogesterone Acetate—Mediastinal disorder—Epirubicin—pancreatic cancer	8.46e-05	0.000282	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Docetaxel—pancreatic cancer	8.46e-05	0.000281	CcSEcCtD
Medroxyprogesterone Acetate—Chills—Epirubicin—pancreatic cancer	8.43e-05	0.00028	CcSEcCtD
Medroxyprogesterone Acetate—Visual impairment—Doxorubicin—pancreatic cancer	8.37e-05	0.000279	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Epirubicin—pancreatic cancer	8.3e-05	0.000276	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Gemcitabine—pancreatic cancer	8.28e-05	0.000276	CcSEcCtD
Medroxyprogesterone Acetate—Mental disorder—Epirubicin—pancreatic cancer	8.23e-05	0.000274	CcSEcCtD
Medroxyprogesterone Acetate—Erythema multiforme—Doxorubicin—pancreatic cancer	8.22e-05	0.000273	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Epirubicin—pancreatic cancer	8.18e-05	0.000272	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Epirubicin—pancreatic cancer	8.18e-05	0.000272	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Docetaxel—pancreatic cancer	8.15e-05	0.000271	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Fluorouracil—pancreatic cancer	8.14e-05	0.000271	CcSEcCtD
Medroxyprogesterone Acetate—Eye disorder—Doxorubicin—pancreatic cancer	8.12e-05	0.00027	CcSEcCtD
Medroxyprogesterone Acetate—Tinnitus—Doxorubicin—pancreatic cancer	8.1e-05	0.00027	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Docetaxel—pancreatic cancer	8.09e-05	0.000269	CcSEcCtD
Medroxyprogesterone Acetate—Cardiac disorder—Doxorubicin—pancreatic cancer	8.06e-05	0.000268	CcSEcCtD
Medroxyprogesterone Acetate—Flatulence—Epirubicin—pancreatic cancer	8.06e-05	0.000268	CcSEcCtD
Medroxyprogesterone Acetate—Tension—Epirubicin—pancreatic cancer	8.02e-05	0.000267	CcSEcCtD
Medroxyprogesterone Acetate—Dysgeusia—Epirubicin—pancreatic cancer	8.01e-05	0.000266	CcSEcCtD
Medroxyprogesterone Acetate—Nervousness—Epirubicin—pancreatic cancer	7.94e-05	0.000264	CcSEcCtD
Medroxyprogesterone Acetate—Back pain—Epirubicin—pancreatic cancer	7.91e-05	0.000263	CcSEcCtD
Medroxyprogesterone Acetate—Angiopathy—Doxorubicin—pancreatic cancer	7.88e-05	0.000262	CcSEcCtD
Medroxyprogesterone Acetate—Muscle spasms—Epirubicin—pancreatic cancer	7.86e-05	0.000262	CcSEcCtD
Medroxyprogesterone Acetate—Immune system disorder—Doxorubicin—pancreatic cancer	7.85e-05	0.000261	CcSEcCtD
Medroxyprogesterone Acetate—Mediastinal disorder—Doxorubicin—pancreatic cancer	7.83e-05	0.000261	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Docetaxel—pancreatic cancer	7.82e-05	0.00026	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Docetaxel—pancreatic cancer	7.82e-05	0.00026	CcSEcCtD
Medroxyprogesterone Acetate—Chills—Doxorubicin—pancreatic cancer	7.8e-05	0.000259	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Doxorubicin—pancreatic cancer	7.68e-05	0.000256	CcSEcCtD
Medroxyprogesterone Acetate—Mental disorder—Doxorubicin—pancreatic cancer	7.61e-05	0.000253	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Epirubicin—pancreatic cancer	7.59e-05	0.000252	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Doxorubicin—pancreatic cancer	7.56e-05	0.000252	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Doxorubicin—pancreatic cancer	7.56e-05	0.000252	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Epirubicin—pancreatic cancer	7.56e-05	0.000251	CcSEcCtD
Medroxyprogesterone Acetate—Agitation—Epirubicin—pancreatic cancer	7.51e-05	0.00025	CcSEcCtD
Medroxyprogesterone Acetate—Flatulence—Doxorubicin—pancreatic cancer	7.45e-05	0.000248	CcSEcCtD
Medroxyprogesterone Acetate—Tension—Doxorubicin—pancreatic cancer	7.42e-05	0.000247	CcSEcCtD
Medroxyprogesterone Acetate—Dysgeusia—Doxorubicin—pancreatic cancer	7.41e-05	0.000246	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Epirubicin—pancreatic cancer	7.37e-05	0.000245	CcSEcCtD
Medroxyprogesterone Acetate—Nervousness—Doxorubicin—pancreatic cancer	7.35e-05	0.000244	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Epirubicin—pancreatic cancer	7.35e-05	0.000244	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Epirubicin—pancreatic cancer	7.33e-05	0.000244	CcSEcCtD
Medroxyprogesterone Acetate—Back pain—Doxorubicin—pancreatic cancer	7.32e-05	0.000243	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Docetaxel—pancreatic cancer	7.29e-05	0.000243	CcSEcCtD
Medroxyprogesterone Acetate—Muscle spasms—Doxorubicin—pancreatic cancer	7.27e-05	0.000242	CcSEcCtD
Medroxyprogesterone Acetate—Palpitations—Epirubicin—pancreatic cancer	7.22e-05	0.00024	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Epirubicin—pancreatic cancer	7.19e-05	0.000239	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Docetaxel—pancreatic cancer	7.1e-05	0.000236	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Epirubicin—pancreatic cancer	7.08e-05	0.000236	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Doxorubicin—pancreatic cancer	7.02e-05	0.000234	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Docetaxel—pancreatic cancer	7e-05	0.000233	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Doxorubicin—pancreatic cancer	6.99e-05	0.000233	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Epirubicin—pancreatic cancer	6.96e-05	0.000232	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Epirubicin—pancreatic cancer	6.96e-05	0.000232	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Epirubicin—pancreatic cancer	6.96e-05	0.000232	CcSEcCtD
Medroxyprogesterone Acetate—Agitation—Doxorubicin—pancreatic cancer	6.95e-05	0.000231	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Epirubicin—pancreatic cancer	6.94e-05	0.000231	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	6.91e-05	0.00023	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Epirubicin—pancreatic cancer	6.88e-05	0.000229	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Doxorubicin—pancreatic cancer	6.82e-05	0.000227	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Epirubicin—pancreatic cancer	6.81e-05	0.000227	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Doxorubicin—pancreatic cancer	6.8e-05	0.000226	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Doxorubicin—pancreatic cancer	6.78e-05	0.000226	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Docetaxel—pancreatic cancer	6.77e-05	0.000225	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Epirubicin—pancreatic cancer	6.73e-05	0.000224	CcSEcCtD
Medroxyprogesterone Acetate—Palpitations—Doxorubicin—pancreatic cancer	6.68e-05	0.000222	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Epirubicin—pancreatic cancer	6.67e-05	0.000222	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Epirubicin—pancreatic cancer	6.67e-05	0.000222	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Doxorubicin—pancreatic cancer	6.65e-05	0.000221	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Epirubicin—pancreatic cancer	6.63e-05	0.000221	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Epirubicin—pancreatic cancer	6.56e-05	0.000218	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Doxorubicin—pancreatic cancer	6.55e-05	0.000218	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Epirubicin—pancreatic cancer	6.54e-05	0.000218	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Docetaxel—pancreatic cancer	6.54e-05	0.000218	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Epirubicin—pancreatic cancer	6.53e-05	0.000217	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Epirubicin—pancreatic cancer	6.51e-05	0.000217	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Epirubicin—pancreatic cancer	6.48e-05	0.000216	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Epirubicin—pancreatic cancer	6.45e-05	0.000215	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Doxorubicin—pancreatic cancer	6.44e-05	0.000214	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Doxorubicin—pancreatic cancer	6.44e-05	0.000214	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Doxorubicin—pancreatic cancer	6.44e-05	0.000214	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Doxorubicin—pancreatic cancer	6.42e-05	0.000214	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	6.4e-05	0.000213	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Doxorubicin—pancreatic cancer	6.36e-05	0.000212	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Epirubicin—pancreatic cancer	6.36e-05	0.000212	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Doxorubicin—pancreatic cancer	6.3e-05	0.00021	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Docetaxel—pancreatic cancer	6.29e-05	0.000209	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Docetaxel—pancreatic cancer	6.24e-05	0.000208	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Epirubicin—pancreatic cancer	6.23e-05	0.000207	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Docetaxel—pancreatic cancer	6.23e-05	0.000207	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Doxorubicin—pancreatic cancer	6.23e-05	0.000207	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Docetaxel—pancreatic cancer	6.2e-05	0.000206	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Doxorubicin—pancreatic cancer	6.17e-05	0.000205	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Doxorubicin—pancreatic cancer	6.17e-05	0.000205	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Doxorubicin—pancreatic cancer	6.13e-05	0.000204	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	6.08e-05	0.000202	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Doxorubicin—pancreatic cancer	6.07e-05	0.000202	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Doxorubicin—pancreatic cancer	6.05e-05	0.000201	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Doxorubicin—pancreatic cancer	6.04e-05	0.000201	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Epirubicin—pancreatic cancer	6.03e-05	0.000201	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Doxorubicin—pancreatic cancer	6.03e-05	0.0002	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Doxorubicin—pancreatic cancer	6e-05	0.0002	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Epirubicin—pancreatic cancer	5.99e-05	0.000199	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Doxorubicin—pancreatic cancer	5.97e-05	0.000199	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Epirubicin—pancreatic cancer	5.95e-05	0.000198	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Epirubicin—pancreatic cancer	5.93e-05	0.000197	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Doxorubicin—pancreatic cancer	5.88e-05	0.000196	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Docetaxel—pancreatic cancer	5.88e-05	0.000196	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Epirubicin—pancreatic cancer	5.87e-05	0.000195	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Epirubicin—pancreatic cancer	5.8e-05	0.000193	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Doxorubicin—pancreatic cancer	5.77e-05	0.000192	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Epirubicin—pancreatic cancer	5.76e-05	0.000192	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Epirubicin—pancreatic cancer	5.75e-05	0.000191	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Epirubicin—pancreatic cancer	5.71e-05	0.00019	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	5.62e-05	0.000187	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Doxorubicin—pancreatic cancer	5.58e-05	0.000186	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Doxorubicin—pancreatic cancer	5.54e-05	0.000184	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Doxorubicin—pancreatic cancer	5.5e-05	0.000183	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Epirubicin—pancreatic cancer	5.5e-05	0.000183	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Doxorubicin—pancreatic cancer	5.49e-05	0.000183	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Epirubicin—pancreatic cancer	5.46e-05	0.000182	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Doxorubicin—pancreatic cancer	5.43e-05	0.000181	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Doxorubicin—pancreatic cancer	5.37e-05	0.000179	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	5.33e-05	0.000177	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Doxorubicin—pancreatic cancer	5.32e-05	0.000177	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Epirubicin—pancreatic cancer	5.3e-05	0.000176	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Doxorubicin—pancreatic cancer	5.28e-05	0.000176	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Epirubicin—pancreatic cancer	5.27e-05	0.000176	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Epirubicin—pancreatic cancer	5.27e-05	0.000176	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Doxorubicin—pancreatic cancer	5.09e-05	0.000169	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Doxorubicin—pancreatic cancer	5.05e-05	0.000168	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Epirubicin—pancreatic cancer	4.92e-05	0.000164	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Doxorubicin—pancreatic cancer	4.9e-05	0.000163	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Doxorubicin—pancreatic cancer	4.88e-05	0.000162	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Doxorubicin—pancreatic cancer	4.88e-05	0.000162	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Epirubicin—pancreatic cancer	4.79e-05	0.000159	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Epirubicin—pancreatic cancer	4.72e-05	0.000157	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Epirubicin—pancreatic cancer	4.57e-05	0.000152	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Doxorubicin—pancreatic cancer	4.55e-05	0.000151	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Doxorubicin—pancreatic cancer	4.43e-05	0.000147	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Epirubicin—pancreatic cancer	4.41e-05	0.000147	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Doxorubicin—pancreatic cancer	4.37e-05	0.000145	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Epirubicin—pancreatic cancer	4.24e-05	0.000141	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Doxorubicin—pancreatic cancer	4.22e-05	0.000141	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Epirubicin—pancreatic cancer	4.21e-05	0.00014	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Epirubicin—pancreatic cancer	4.2e-05	0.00014	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Epirubicin—pancreatic cancer	4.18e-05	0.000139	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Doxorubicin—pancreatic cancer	4.08e-05	0.000136	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Epirubicin—pancreatic cancer	3.96e-05	0.000132	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Doxorubicin—pancreatic cancer	3.93e-05	0.000131	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Doxorubicin—pancreatic cancer	3.89e-05	0.00013	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Doxorubicin—pancreatic cancer	3.89e-05	0.000129	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Doxorubicin—pancreatic cancer	3.87e-05	0.000129	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Doxorubicin—pancreatic cancer	3.67e-05	0.000122	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—AKT1—pancreatic cancer	3.49e-05	0.000344	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NRP1—pancreatic cancer	3.48e-05	0.000343	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PPP2R5B—pancreatic cancer	3.48e-05	0.000343	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—HES1—pancreatic cancer	3.47e-05	0.000342	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	3.45e-05	0.00034	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—EZH2—pancreatic cancer	3.43e-05	0.000338	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PRSS1—pancreatic cancer	3.43e-05	0.000338	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—GCG—pancreatic cancer	3.4e-05	0.000336	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—APOE—pancreatic cancer	3.39e-05	0.000335	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—EZH2—pancreatic cancer	3.38e-05	0.000333	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—NOTCH3—pancreatic cancer	3.36e-05	0.000331	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HEY2—pancreatic cancer	3.35e-05	0.00033	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—NOTCH3—pancreatic cancer	3.31e-05	0.000326	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—SMAD4—pancreatic cancer	3.28e-05	0.000324	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—GAST—pancreatic cancer	3.27e-05	0.000322	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—AGTR1—pancreatic cancer	3.25e-05	0.00032	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—PIK3CD—pancreatic cancer	3.21e-05	0.000317	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.21e-05	0.000317	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—STK11—pancreatic cancer	3.2e-05	0.000316	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—HSPA1A—pancreatic cancer	3.18e-05	0.000314	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—NOTCH1—pancreatic cancer	3.18e-05	0.000313	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—HSPA1A—pancreatic cancer	3.13e-05	0.000309	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SCT—pancreatic cancer	3.1e-05	0.000306	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HEY1—pancreatic cancer	3.1e-05	0.000306	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PIK3CG—pancreatic cancer	3.06e-05	0.000302	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TERT—pancreatic cancer	3.04e-05	0.0003	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—PPARG—pancreatic cancer	3e-05	0.000296	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ARG2—pancreatic cancer	2.97e-05	0.000293	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CCK—pancreatic cancer	2.96e-05	0.000292	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PPARG—pancreatic cancer	2.96e-05	0.000292	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	2.91e-05	0.000287	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—HIF1A—pancreatic cancer	2.91e-05	0.000287	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TSC2—pancreatic cancer	2.9e-05	0.000286	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—PIK3CA—pancreatic cancer	2.9e-05	0.000286	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CNR2—pancreatic cancer	2.88e-05	0.000284	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—GLP1R—pancreatic cancer	2.88e-05	0.000284	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—APOE—pancreatic cancer	2.84e-05	0.00028	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CCKAR—pancreatic cancer	2.83e-05	0.00028	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—SMAD4—pancreatic cancer	2.8e-05	0.000276	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—PIK3CB—pancreatic cancer	2.8e-05	0.000276	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PRSS1—pancreatic cancer	2.79e-05	0.000275	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—KDR—pancreatic cancer	2.78e-05	0.000274	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—PTGS2—pancreatic cancer	2.78e-05	0.000274	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—JAG2—pancreatic cancer	2.75e-05	0.000271	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—HES1—pancreatic cancer	2.74e-05	0.00027	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MEN1—pancreatic cancer	2.71e-05	0.000267	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—MYC—pancreatic cancer	2.71e-05	0.000267	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PIK3CD—pancreatic cancer	2.69e-05	0.000266	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—NFKBIA—pancreatic cancer	2.64e-05	0.000261	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—NOTCH1—pancreatic cancer	2.62e-05	0.000258	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—TYMP—pancreatic cancer	2.6e-05	0.000256	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SHH—pancreatic cancer	2.58e-05	0.000255	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NOTCH4—pancreatic cancer	2.57e-05	0.000253	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—PIK3CG—pancreatic cancer	2.56e-05	0.000253	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IAPP—pancreatic cancer	2.55e-05	0.000252	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—EGF—pancreatic cancer	2.53e-05	0.00025	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—SMAD4—pancreatic cancer	2.53e-05	0.000249	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—SMAD4—pancreatic cancer	2.49e-05	0.000246	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—CTNNB1—pancreatic cancer	2.48e-05	0.000245	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PTHLH—pancreatic cancer	2.45e-05	0.000242	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PTCH1—pancreatic cancer	2.45e-05	0.000242	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—PTEN—pancreatic cancer	2.42e-05	0.000239	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—NOTCH1—pancreatic cancer	2.42e-05	0.000239	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ARG2—pancreatic cancer	2.42e-05	0.000238	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TERT—pancreatic cancer	2.4e-05	0.000236	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—AKT1—pancreatic cancer	2.37e-05	0.000233	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PIK3CB—pancreatic cancer	2.35e-05	0.000231	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PTGS2—pancreatic cancer	2.33e-05	0.000229	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—HIF1A—pancreatic cancer	2.29e-05	0.000226	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TSC2—pancreatic cancer	2.29e-05	0.000226	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—PPARG—pancreatic cancer	2.28e-05	0.000225	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—PIK3CD—pancreatic cancer	2.25e-05	0.000222	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—SRC—pancreatic cancer	2.25e-05	0.000221	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SST—pancreatic cancer	2.24e-05	0.000221	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—APOE—pancreatic cancer	2.24e-05	0.000221	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—KDR—pancreatic cancer	2.19e-05	0.000216	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—JAG1—pancreatic cancer	2.19e-05	0.000216	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NOTCH3—pancreatic cancer	2.18e-05	0.000215	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—STAT3—pancreatic cancer	2.17e-05	0.000214	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—NRAS—pancreatic cancer	2.16e-05	0.000213	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.14e-05	0.000211	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—TYMP—pancreatic cancer	2.11e-05	0.000208	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GLP1R—pancreatic cancer	2.09e-05	0.000206	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—NFKBIA—pancreatic cancer	2.09e-05	0.000206	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—MYC—pancreatic cancer	2.08e-05	0.000206	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CNR1—pancreatic cancer	2.07e-05	0.000204	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—NOTCH1—pancreatic cancer	2.07e-05	0.000204	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—DPYD—pancreatic cancer	2.06e-05	0.000203	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—MYC—pancreatic cancer	2.05e-05	0.000202	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PTEN—pancreatic cancer	2.03e-05	0.0002	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PIK3CG—pancreatic cancer	2.02e-05	0.000199	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—MYC—pancreatic cancer	2.01e-05	0.000198	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—TGFB1—pancreatic cancer	2.01e-05	0.000198	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—GCG—pancreatic cancer	2e-05	0.000197	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—EGF—pancreatic cancer	2e-05	0.000197	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—EGFR—pancreatic cancer	1.97e-05	0.000194	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—PIK3CB—pancreatic cancer	1.96e-05	0.000194	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—SLC2A2—pancreatic cancer	1.95e-05	0.000193	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.93e-05	0.000191	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—AGTR1—pancreatic cancer	1.91e-05	0.000188	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CXCL8—pancreatic cancer	1.89e-05	0.000186	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—STK11—pancreatic cancer	1.88e-05	0.000185	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.87e-05	0.000184	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—NOTCH1—pancreatic cancer	1.86e-05	0.000184	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—KRAS—pancreatic cancer	1.86e-05	0.000183	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.84e-05	0.000181	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—NOTCH1—pancreatic cancer	1.84e-05	0.000181	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CASP3—pancreatic cancer	1.8e-05	0.000178	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PIK3CD—pancreatic cancer	1.78e-05	0.000175	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—PPARG—pancreatic cancer	1.76e-05	0.000174	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CCND1—pancreatic cancer	1.76e-05	0.000173	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.74e-05	0.000172	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CTNNB1—pancreatic cancer	1.74e-05	0.000172	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—PPARG—pancreatic cancer	1.73e-05	0.000171	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—MYC—pancreatic cancer	1.71e-05	0.000169	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—PIK3CA—pancreatic cancer	1.71e-05	0.000168	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MMP9—pancreatic cancer	1.71e-05	0.000168	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GLP1R—pancreatic cancer	1.7e-05	0.000168	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.7e-05	0.000168	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—PTEN—pancreatic cancer	1.7e-05	0.000167	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—DPYD—pancreatic cancer	1.68e-05	0.000165	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SMAD4—pancreatic cancer	1.64e-05	0.000162	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HES1—pancreatic cancer	1.61e-05	0.000158	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.59e-05	0.000157	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	1.59e-05	0.000157	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—HRAS—pancreatic cancer	1.58e-05	0.000156	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.57e-05	0.000155	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—SRC—pancreatic cancer	1.57e-05	0.000155	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PIK3CB—pancreatic cancer	1.55e-05	0.000153	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—VEGFA—pancreatic cancer	1.53e-05	0.000151	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.52e-05	0.00015	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—STAT3—pancreatic cancer	1.52e-05	0.00015	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CD44—pancreatic cancer	1.51e-05	0.000149	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—NRAS—pancreatic cancer	1.51e-05	0.000149	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CXCL8—pancreatic cancer	1.49e-05	0.000147	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.48e-05	0.000146	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.47e-05	0.000145	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GCG—pancreatic cancer	1.45e-05	0.000143	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PIK3CA—pancreatic cancer	1.43e-05	0.000141	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CASP3—pancreatic cancer	1.42e-05	0.00014	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MYC—pancreatic cancer	1.41e-05	0.000139	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TERT—pancreatic cancer	1.41e-05	0.000139	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TGFB1—pancreatic cancer	1.41e-05	0.000139	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—AKT1—pancreatic cancer	1.4e-05	0.000138	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.39e-05	0.000137	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CCND1—pancreatic cancer	1.39e-05	0.000137	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.38e-05	0.000136	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—EGFR—pancreatic cancer	1.38e-05	0.000136	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CTNNB1—pancreatic cancer	1.37e-05	0.000135	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—STK11—pancreatic cancer	1.36e-05	0.000135	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HIF1A—pancreatic cancer	1.35e-05	0.000133	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MMP9—pancreatic cancer	1.35e-05	0.000133	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TSC2—pancreatic cancer	1.34e-05	0.000132	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PTEN—pancreatic cancer	1.34e-05	0.000132	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—APOE—pancreatic cancer	1.31e-05	0.00013	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—MYC—pancreatic cancer	1.3e-05	0.000128	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—KRAS—pancreatic cancer	1.3e-05	0.000128	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—KDR—pancreatic cancer	1.29e-05	0.000127	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.28e-05	0.000126	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—SRC—pancreatic cancer	1.24e-05	0.000122	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CD44—pancreatic cancer	1.23e-05	0.000121	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NFKBIA—pancreatic cancer	1.22e-05	0.000121	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NOTCH1—pancreatic cancer	1.21e-05	0.00012	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—VEGFA—pancreatic cancer	1.21e-05	0.000119	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.21e-05	0.000119	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—STAT3—pancreatic cancer	1.2e-05	0.000118	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—PIK3CA—pancreatic cancer	1.2e-05	0.000118	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.19e-05	0.000118	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—NRAS—pancreatic cancer	1.19e-05	0.000118	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PIK3CG—pancreatic cancer	1.19e-05	0.000117	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—AKT1—pancreatic cancer	1.19e-05	0.000117	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GCG—pancreatic cancer	1.18e-05	0.000116	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—TYMS—pancreatic cancer	1.17e-05	0.000116	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—EGF—pancreatic cancer	1.17e-05	0.000116	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—AKT1—pancreatic cancer	1.17e-05	0.000115	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TP53—pancreatic cancer	1.16e-05	0.000114	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GLP1R—pancreatic cancer	1.12e-05	0.000111	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MYC—pancreatic cancer	1.11e-05	0.00011	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—STK11—pancreatic cancer	1.11e-05	0.000109	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TGFB1—pancreatic cancer	1.11e-05	0.000109	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—HRAS—pancreatic cancer	1.11e-05	0.000109	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—DPYD—pancreatic cancer	1.11e-05	0.000109	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—EGFR—pancreatic cancer	1.09e-05	0.000107	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	1.05e-05	0.000103	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PIK3CD—pancreatic cancer	1.04e-05	0.000103	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.04e-05	0.000103	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—KRAS—pancreatic cancer	1.03e-05	0.000101	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—MYC—pancreatic cancer	1e-05	9.9e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—MYC—pancreatic cancer	9.88e-06	9.75e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—AKT1—pancreatic cancer	9.77e-06	9.64e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—TYMS—pancreatic cancer	9.55e-06	9.42e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—APOE—pancreatic cancer	9.54e-06	9.41e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PIK3CA—pancreatic cancer	9.44e-06	9.31e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TP53—pancreatic cancer	9.13e-06	9e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PIK3CB—pancreatic cancer	9.08e-06	8.96e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—AKT1—pancreatic cancer	9.03e-06	8.91e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	9.03e-06	8.91e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CXCL8—pancreatic cancer	8.73e-06	8.61e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—HRAS—pancreatic cancer	8.73e-06	8.61e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	8.61e-06	8.49e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CASP3—pancreatic cancer	8.36e-06	8.24e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PPARG—pancreatic cancer	8.31e-06	8.2e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CCND1—pancreatic cancer	8.13e-06	8.02e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CD44—pancreatic cancer	8.12e-06	8.01e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CTNNB1—pancreatic cancer	8.05e-06	7.94e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MMP9—pancreatic cancer	7.9e-06	7.79e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PTEN—pancreatic cancer	7.85e-06	7.74e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GCG—pancreatic cancer	7.79e-06	7.68e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—APOE—pancreatic cancer	7.76e-06	7.66e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—AKT1—pancreatic cancer	7.71e-06	7.6e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	7.57e-06	7.47e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	7.35e-06	7.25e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—STK11—pancreatic cancer	7.32e-06	7.22e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SRC—pancreatic cancer	7.28e-06	7.18e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—VEGFA—pancreatic cancer	7.09e-06	6.99e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—STAT3—pancreatic cancer	7.02e-06	6.92e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	7.01e-06	6.91e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NRAS—pancreatic cancer	7e-06	6.91e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—AKT1—pancreatic cancer	6.96e-06	6.86e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—AKT1—pancreatic cancer	6.85e-06	6.76e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PPARG—pancreatic cancer	6.76e-06	6.67e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	6.6e-06	6.51e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PTGS2—pancreatic cancer	6.54e-06	6.45e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MYC—pancreatic cancer	6.52e-06	6.43e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TGFB1—pancreatic cancer	6.51e-06	6.42e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—EGFR—pancreatic cancer	6.38e-06	6.29e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—TYMS—pancreatic cancer	6.3e-06	6.21e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	6.16e-06	6.08e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—KRAS—pancreatic cancer	6.03e-06	5.95e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PTEN—pancreatic cancer	5.7e-06	5.62e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PIK3CA—pancreatic cancer	5.54e-06	5.46e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	5.37e-06	5.3e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TP53—pancreatic cancer	5.36e-06	5.28e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PTGS2—pancreatic cancer	5.32e-06	5.25e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HRAS—pancreatic cancer	5.12e-06	5.05e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—APOE—pancreatic cancer	5.12e-06	5.05e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PTEN—pancreatic cancer	4.64e-06	4.58e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	4.62e-06	4.56e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—AKT1—pancreatic cancer	4.52e-06	4.46e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PPARG—pancreatic cancer	4.46e-06	4.4e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	4.06e-06	4.01e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	4.02e-06	3.97e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	3.54e-06	3.49e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PTGS2—pancreatic cancer	3.51e-06	3.46e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—AKT1—pancreatic cancer	3.29e-06	3.24e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	3.27e-06	3.23e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PTEN—pancreatic cancer	3.06e-06	3.02e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—AKT1—pancreatic cancer	2.67e-06	2.64e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	2.16e-06	2.13e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.76e-06	1.74e-05	CbGpPWpGaD
